Patents by Inventor Eric Massana Montejo

Eric Massana Montejo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 5-(2-1-HYDROXYETHYL)-8-HYDROXYQUINOLIN-2(1H)-ONE FOR THE TREATMENT OF LUNG FUNCTION
    Publication number: 20140343097
    Abstract: A compound which is a hydroxyquinolinone derivative of formula (I), in the form of a racemate, a stereoisomer or a mixture of stereoisomers, or a pharmaceutically acceptable salt or solvate thereof, for use in, for example, normalising the lung function of a human patient.
    Type: Application
    Filed: March 26, 2014
    Publication date: November 20, 2014
    Applicant: ALMIRALL, S.A.
    Inventors: Thorsten RUF, Eric MASSANA MONTEJO
  • 5-(2--1-HYDROXYETHYL-8-HYDROXYQUINOLIN-2 (1H)-ONE AND ITS USE IN THE TREATMENT OF PULMONARY DISEASES
    Publication number: 20140038928
    Abstract: The present invention provides a compound which is a hydroxyquinolinone derivative of formula (I), in the form of a racemate, a stereoisomer or a mixture of stereoisomers, or a pharmaceutically acceptable salt or solvate thereof, for use in a method of treating a pulmonary disease or condition associated with ?2 adrenergic receptor activity in a mammal, in which the compound is administered by the inhalatory route at a metered nominal dose of less than 5 ?g.
    Type: Application
    Filed: October 8, 2013
    Publication date: February 6, 2014
    Applicant: ALMIRALL, S.A.
    Inventors: Thorsten RUF, Eric Massana Montejo
  • 5-(2--1-HYDROXYETHYL)-8-HYDROXYQUINOLIN-2(1H)-ONE AND ITS USE IN THE TREATMENT OF PULMONARY DISEASES
    Publication number: 20120040941
    Abstract: The present invention provides a compound, which is a hydroxyquinolinone derivative of formula (I), in the form of a racemate, a stereoisomer or a mixture of stereoisomers, or a pharmaceutically acceptable salt or solvate thereof, for use in a method of treating, for example, a pulmonary disease or condition associated with ?2 adrenergic receptor activity in a mammal, in which the compound is administered by the inhalatory route at a metered nominal dose of less than 5 ?g.
    Type: Application
    Filed: February 18, 2010
    Publication date: February 16, 2012
    Inventors: Thorsten Ruf, Eric Massana Montejo
  • 5-(2--1-HYDROXYETHYL)-8-HYDROXYQUINOLIN-2 (1H)-ONE FOR THE TREATMENT OF LUNG FUNCTION
    Publication number: 20120029014
    Abstract: A compound which is a hydroxyquinolinone derivative of formula (I), in the form of a racemate, a steroisomer or a mixture of stereoisomers, or a pharmaceutically acceptable salt or solvate thereof, for use in, for example, normalising the lung function of a human patient.
    Type: Application
    Filed: February 18, 2010
    Publication date: February 2, 2012
    Applicant: ALMIRALL, S.A.
    Inventors: Thorsten Ruf, Eric Massana Montejo